A case report of advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy and sorafenib combination therapy followed by metastasectomy of lung and muscle metastases

Currently, various tyrosine kinase inhibitors and immune checkpoint inhibitors have been suggested in the treatment guidelines for advanced hepatocellular carcinoma (HCC). However, sorafenib was the only systemic drug approved 10 years ago. In 2010, a woman diagnosed with HCC rupture and multiple lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Sang Yi, Han, Sang Young, Baek, Yang-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035714/
https://www.ncbi.nlm.nih.gov/pubmed/37383533
http://dx.doi.org/10.17998/jlc.2021.12.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035714/
https://www.ncbi.nlm.nih.gov/pubmed/37383533
http://dx.doi.org/10.17998/jlc.2021.12.20

Ejemplares similares